Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Zachary Skelding
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-47
properties)
Infobox
Patent primary examiner of
US Patent 7696338 Immunotoxin fusion proteins and means for expression thereof
US Patent 7744863 Method of inducing immune tolerance
US Patent 7754210 Inotropic antibodies and therapeutic uses thereof
US Patent 7754213 High affinity antibody antagonists of interleukin-13 receptor alpha 1
US Patent 7754217 HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
US Patent 7754853 TNF alpha-binding polypeptide compositions and methods
US Patent 7785590 Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1)
US Patent 7794715 Anti-TIRC7 antibodies in therapy of inflammatory diseases
US Patent 7807158 Antibodies against IL-13 receptor alpha1 and uses thereof
US Patent 7807168 Selection of human TNFα specific antibodies
US Patent 7807463 Pre-transplant accommodated organs resistant to anti-donor immunity
US Patent 7820166 Potent T cell modulating molecules
US Patent 7820168 Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17
US Patent 7820174 T cell receptors and related materials and methods of use
US Patent 7820620 Cripto antagonism of activin and TGF-b signaling
US Patent 7829090 Human antibody molecules for IL-13
US Patent 7829097 Use of HMGB1 for protection against ischemia reperfusion injury
US Patent 7846439 Domain antibody construct
US Patent 7858095 Method for treating or preventing sclerotic disorders using CD-2 binding agents
US Patent 7867475 Immune regulation based on the depletion of CD69+ cells
US Patent 7871606 Use of stimulated peripheral-blood mononuclear cells for the treatment of cancerous diseases
US Patent 7872113 Nucleic acids encoding antibodies that bind interleukin-4 receptor
US Patent 7875427 Compositions and methods for IL-13 biomarkers
US Patent 7879985 Antibodies against human NKG2D and uses thereof
US Patent 7883703 Methods of modulating immunity
US Patent 7883705 Anti FGF23 antibody and a pharmaceutical composition comprising the same
US Patent 7883707 Induction of antigen specific immunnologic tolerance
US Patent 7887811 Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein
US Patent 7888484 Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
US Patent 7892550 Anti-cmet antibodies
US Patent 7897743 Humanized GM-CSF antibodies
US Patent 7919094 Methods for treating conditions associated with MASP-2 dependent complement activation
US Patent 7923012 Antibody against fibroblast growth factor-23
US Patent 7931901 T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
US Patent 7935343 Human antibody molecules for IL-13
US Patent 7935344 Human anti-IL-23 antibodies, compositions, methods and uses
US Patent 7939076 Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist
US Patent 7939295 Methods for reducing immunogenicity of polypeptides
US Patent 7947272 Compositions and methods of tolerizing a primate to an antigen
US Patent 7947273 Human antibody molecules for IL-13
US Patent 7947464 Method for identifying regulatory T cells
US Patent 7951783 Therapeutically useful molecules
US Patent 7955598 Therapeutic agent for chronic arthritides diseases of childhood-related diseases
US Patent 7960125 Identification of thymically derived CD4 T cells by protein tyrosine kinase 7 expression
US Patent 7985409 Tr1 cells for use in atherosclerosis
US Patent 7993645 Human anti-IL-23 antibodies, compositions, methods and uses
US Patent 7998926 Dimerized T-cell receptor fragment, its compositions and use
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7998926 Dimerized T-cell receptor fragment, its compositions and use
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7993645 Human anti-IL-23 antibodies, compositions, methods and uses
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7985409 Tr1 cells for use in atherosclerosis
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7960125 Identification of thymically derived CD4 T cells by protein tyrosine kinase 7 expression
Edits on 7 Dec, 2021
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7955598 Therapeutic agent for chronic arthritides diseases of childhood-related diseases
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7951783 Therapeutically useful molecules
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7947464 Method for identifying regulatory T cells
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7947273 Human antibody molecules for IL-13
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7947272 Compositions and methods of tolerizing a primate to an antigen
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7939295 Methods for reducing immunogenicity of polypeptides
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7939076 Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7935343 Human antibody molecules for IL-13
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7935344 Human anti-IL-23 antibodies, compositions, methods and uses
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7931901 T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7923012 Antibody against fibroblast growth factor-23
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7919094 Methods for treating conditions associated with MASP-2 dependent complement activation
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7897743 Humanized GM-CSF antibodies
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7892550 Anti-cmet antibodies
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7888484 Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
Load more
Find more people like Zachary Skelding
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE